Putting policy and procedures into place is one of the best ways to navigate compliance in the novel area between healthcare and technology, says Sara Helene Shanti, a partner in Sheppard Mullin’s Corporate Practice Group in Chicago.  

The Food and Drug Administration is sounding the warning bell on counterfeit versions of the weight loss medication Ozempic, saying fakes cause possible infection risks. The agency said it has seized thousands of units of the product, which has crept its way into the legitimate U.S. drug supply chain. 

The respiratory disease known as respiratory syncytial virus (RSV) has led to more emergency hospitalizations than the flu and the Omicron variant of COVID-19, according to recent findings in JAMA. 

Blue Shield of California is reducing its staffing by 140 positions, or about 2% of the workforce.